Melatonin inhibits fatty acid transport in inguinal fat pads of hepatoma 7288CTC-bearing and normal Buffalo rats via receptor-mediated signal transduction

Life Sciences

Volumn 68, Issue 25, 2001, Pages 2835-2844

  Sauer, Leonard A ^a   Dauchy, Robert T ^a   Blask, David E ^a  

^a BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

Fatty acid transport; Inguinal fat pad; Melatonin; Rats

Indexed keywords

8 BROMO CYCLIC AMP; FATTY ACID; FORSKOLIN; MELATONIN; N [2 (1 NAPHTHYL)ETHYL]CYCLOBUTANECARBOXAMIDE; PERTUSSIS TOXIN; PROTEIN G; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATTY ACID TRANSPORT; HEPATOMA CELL; INGUINAL REGION; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADIPOSE TISSUE; ANIMALS; BIOLOGICAL TRANSPORT; CIRCADIAN RHYTHM; FORSKOLIN; LINOLEIC ACID; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MELATONIN; NAPHTHALENES; NEOPLASM TRANSPLANTATION; PERTUSSIS TOXIN; RATS; RATS, INBRED BUF; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; TIME FACTORS; VIRULENCE FACTORS, BORDETELLA;

EID: 0035844047     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01062-1     Document Type: Article

References (26)

1. D.E. Blask, L.A. Sauer, R.T. Dauchy, E.W. Holowachuk, M.S. Ruhoff and H.S. Kopff. CanCer Res. 59 4693-4701 (1999).
2. L.A. Sauer, R.T. Dauchy and D.E. Blask. J. Nutr. 127 1412-1421 (1997).
3. L.A. Sauer, R.T. Dauchy, D.E. Blask, B.J. Armstrong and S. Scalisi. Cancer Res. 59 4688-4692 (1999).
4. L.A. Sauer and R.T. Dauchy. Brit. J. Cancer 66 290-296 (1992).
5. L.A. Sauer and R.T. Dauchy. Cancer Res. 47 1065-1068 (1987).
6. L.A. Sauer and R.T. Dauchy. Cancer Res. 47 1756-1761 (1987).
7. S.A. Beck and M.J. Tisdale. Cancer Res. 47 5919-5923 (1987).
8. T. Wolden-Hanson, D.R. Mitton, R.L. McCants, S.M. Yellon, C.W. Wilkinson, A.M. Matsumoto and D.D. Rasmussen. Endocrinol. 141 487-497, (2000)
9. P. Lissoni, F. Paolorossi, G. Tancini, S. Barni, A. Ardizzoia, F. Brivio, B. Zubelewicz and V. Chatikhine. Eur. J. Cancer 32A 1340-1343 (1996).
10. L.A. Sauer, and R.T. Dauchy. Cancer Res. 48 3106-3111 (1988).
11. B. Guardiola-Lemaitre and P. Delagrange. Melatonin Agonists and Antagonists: Pharmacological Tools or Therapeutic Agents? S.M. Webb, M. Puig-Domingo, M. Moller, and P. Pevet (Eds.), 301-319, PJD Publications Westbury (1997).
12. L.A. Sauer and R.T. Dauchy. Metabolism 43 1488-1497 (1994).
13. S.A. Glantz. Primer of Biostatistics. Ed. 3, McGraw-Hill, New York (1992).
14. R.J. Reiter. Trends Endocrinol. Metab. 2 13-19 (1991).
15. R.J. Reiter. Endocr. Rev. 12 151-180 (1991).
16. S.M. Reppert and D.R. Weaver. Cell 83 1059-1062 (1995).
17. W. Stremmel. J. Hepatol. 9 374-382 (1989).
18. B.A. Fitscher, C. Elsing, H.-D. Riedel, J. Gorski and W. Stremmel. Proc. Soc. Exp. Biol. Med. 212 15-23 (1996).
19. N.A. Abumrad, M.R. El-Maghrabi, E-Z. Amri, E. Lopez and P.A. Grimaldi. J. Biol. Chem 268 17665-17668 (1993).
20. J.E. Schaffer and H.F. Lodish. Cell 79 427-435 (1994).
21. L.M. Isola, S.-L. Zhou, C.-L. Kiang, D.D. Stump, M.W. Bradbury and P.D. Berk. Proc. Natl. Acad. Sci. USA 92 9866-9870 (1995)
22. A. Ibrahimi, Z. Sfeir, H. Magharaie, E-Z. Amri, P. Grimaldi and N.A. Abumrad. Proc. Natl. Acad. Sci. USA 93 2646-2651 (1996).
23. A. Bonen, J.J.F.P. Luiken, Y. Arumugam, J.F.C. Glatz and N.N. Tandon. J. Biol. Chem. 275 14501-14508 (2000).
24. D. Hirsch, A. Stahl and H.F. Lodish. Proc. Natl. Acad. Sci. USA 95 8625-8629 (1998).
25. T.Y Hui, B.I. Frohnert, A.J. Smith, J.E. Schaffer and D.A. Bernlohr. J. Biol. Chem. 273 27420-27429 (1998).
26. W.J.M. Hrushesky J. Clin. Oncol. 11 1403-1417 (1993).